Skip to content

Effect of selected Ayurveda and Yoga protocol in Mild Progressive Memory loss

Effect of selected Ayurveda and Yoga protocol in Mild Neurocognitive Disorder – A single group pretest–posttest trial

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053654
Enrollment
21
Registered
2023-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F068- Other specified mental disorders due to known physiological condition

Interventions

None listed

Sponsors

Annu V
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects of Mild Neurocognitive Disorder as per DSM V diagnostic criteria. 2.Those whose MMSE Score between 19-23. 3.Age between 50-70 years. 4.No discrimination of gender, religion, and economic status. 5.Participants indicated for ma?sa nasya. 6.Participants willing to give informed consent.

Exclusion criteria

Exclusion criteria: 1.Known cases of neurological impairment (Stroke, Parkinson disease, significant head trauma and epilepsy). 2.Known case of major psychiatric co-morbidities (major depressive disorder, generalized anxiety disorder, schizophrenia). 3.Known case of alcohol and substance abuse. 4.Known case / under medications for cardiovascular diseases, thyroid dysfunction, chronic kidney, and liver diseases.

Design outcomes

Primary

MeasureTime frame
Montreal Cognitive Assessment (MoCA) on 0th day,8th day,38th day, 68th day. Quality of Life in Alzheimer’s Disease (QOL-AD) scale on 0th day, 68th day. Timepoint: Montreal Cognitive Assessment (MoCA) on 0th day,8th day,38th day, 68th day. Quality of Life in Alzheimer’s Disease (QOL-AD) scale on 0th day, 68th day.

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactVINOD R

VPSV AYURVEDA COLLEGE KOTTAKKAL

drvinodvarier@gmail.com9846302667

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026